Natalija Van Braeckel Budimir

Natalija Van Braeckel Budimir has over 13 years of work experience in the field of Immunology. Natalija began their career in 2008 as a PhD-student at the University of Groningen. After completing their PhD, they worked as a Scientist at Mucosis from 2012 to 2014. From 2014 to 2019, they worked as a Postdoctoral Research Scientist at the University of Iowa. Natalija then joined Pfizer in 2019 as a Senior Scientist and was promoted to Principal Scientist of Cancer Immunology in the same year. Natalija is currently working as the Director of Immunology at Janux Therapeutics.

Natalija Van Braeckel Budimir received their PhD in Viral Immunology from the University of Groningen in 2012. Natalija had previously earned their MSc in Molecular Biology and Physiology from the University of Belgrade in 2005.